Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

French Cross-cultural Adaptation of the Iowa Infant Feeding Attitude Scale (IIFAS) (FRENCH IIFAS)

27. Mai 2026 aktualisiert von: BARASINSKI Chloé, University Hospital, Clermont-Ferrand

French Cross-cultural Adaptation of the Iowa Infant Feeding Attitude Scale (IIFAS) and Assessments of Parental Representations of Infant Feeding During Pregnancy in the Auvergne Perinatal Network.

Our study will consist of two parts:

  • Part 1: Cross-cultural adaptation of the Iowa Infant Feeding Attitude Scale (IIFAS) among postpartum mothers and co-parents in France and assessment of its psychometric properties
  • Part 2: Assessment of cultural representations of infant feeding practices during pregnancy.

The goal of this repeated cross-sectional study is to cross-culturally adapt and evaluate the psychometric properties of the French version of the IIFAS among postpartum mothers in France.

In the part 1 of the study, the main questions it aims to answer are:

  • Evaluation of the psychometric properties of the French version of the Iowa Infant Feeding Attitude Scale (IIFAS) among postpartum mothers in France
  • Evaluation of the psychometric properties of the French version of the Iowa Infant Feeding Attitude Scale (IIFAS) among postpartum co-parents in France

Participants will be asked :

  • to complete the study questionnaires, including the French version of the IIFAS questionnaire.
  • to complete the French version of the IIFAS questionnaire a second time 7 days after their initial completion.
  • to answer 1 to 4 questions about the infant's current feeding regimen 8 weeks after giving birth.

In the part 2, the goal of this descriptive cross-sectional study is to assess cultural representations of infant feeding practices during pregnancy among pregnant women in France during the first and the third trimesters.

In the part 2 of the study, the main questions it aims to answer are:

  • To describe cultural perceptions of infant feeding practices among mothers in France during the first and third trimesters of pregnancy.
  • To describe the cultural perceptions of infant feeding practices among co-parents in France during the first and third trimesters of pregnancy.
  • To compare the cultural perceptions of infant feeding practices among mothers according to the trimester of pregnancy.
  • To analyze the impact of different factors (age, education level, occupation, number of children, geographic origin, socioeconomic status, having been breastfed oneself, having personal experience with breastfeeding, plans to return to work, etc.) on mothers' cultural perceptions of infant feeding practices during the first and third trimesters of pregnancy.
  • To compare co-parents' cultural perceptions of infant feeding methods according to the trimester of pregnancy.
  • To analyze the impact of different factors (age, education level, occupation, number of children, geographic origin, socioeconomic status, having been breastfed oneself, having a child who was previously breastfed, etc.) on co-parents' cultural perceptions of infant feeding methods during the first and third trimesters of pregnancy.
  • To compare the cultural perceptions of infant feeding practices between mothers and co-parents during the first and third trimesters of pregnancy.

Participants will be asked to complete the study questionnaires, including the French version of the IIFAS questionnaire.

Studienübersicht

Status

Noch keine Rekrutierung

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

930

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • France
      • Clermont-Ferrand, France, Frankreich, 63000
        • CHU de Clermont-Ferrand
        • Hauptermittler:
          • Chloé BARASIONSKI

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

N/A

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

For part 1, Our target population will consist of new parents during their stay in the maternity ward at one of the Auvergne Perinatal Network maternity participating in the study.

For part 2, our target population will be expectant parents during pregnancy who are receiving care within the Auvergne Perinatal Network. Participation by both parents is not required for this study.

Beschreibung

Part 1

Inclusion Criteria:

  • Adult women hospitalized for postpartum care in one of the 10 maternity hospitals of the Auvergne perinatal network participating in the project, and/or adult co-parents whose partner is hospitalized in one of the 10 RSPA maternity hospitals participating in the project,
  • Mothers and/or co-parents of a singleton child born alive at term (≥37 weeks' gestation) and hospitalized in the maternity ward,
  • Mothers and/or co-parents of a child less than 6 days old,
  • Mothers and/or co-parents affiliated to a social security scheme,
  • Mothers and/or co-parents capable of reading and understanding French.

Non-inclusion Criteria:

  • Mothers and/or co-parents of a child hospitalized outside the maternity ward,
  • Mothers and/or co-parents who are adults with legal incapacity (under guardianship, conservatorship, or judicial protection),
  • Mothers and/or co-parents who refuse to participate in the study,
  • Mothers with a contraindication to AM and/or co-parents whose spouse has a contraindication to AM,
  • Mothers and/or co-parents of a child with a medical condition or malformation that affects their feeding.

Part 2 during 1st trimester :

Inclusion Criteria:

  • Pregnant adult women who are being cared for by healthcare professional belonging the Auvergne perinatal network and/or their co-parents of legal age, during the first trimester of pregnancy (before 16 weeks and 0 days of gestation),
  • Pregnant women and/or co-parents affiliated to a social security scheme,
  • Pregnant women and/or co-parents who can read and understand French.

Non-inclusion criteria :

  • Pregnant women and/or co-parents in the second trimester of pregnancy (between 16 weeks 0 days and 28 weeks 6 days of gestation),
  • Pregnant women and/or co-parents who are legally incapacitated adults (under guardianship, conservatorship, or judicial protection),
  • Pregnant women and/or co-parents who refuse to participate in the study,
  • Pregnant women with a contraindication to breastfeeding and/or co-parents whose partner has a contraindication to breastfeeding,
  • Pregnant women with a multiple pregnancy and/or co-parents being monitored for a multiple pregnancy.

Part 2 during 3rd trimester :

Inclusion Criteria:

  • Pregnant adult women who are being cared for by healthcare professional belonging the Auvergne perinatal network and/or their co-parents of legal age, during the third trimester of pregnancy (after 28 weeks and 6 days of gestation),
  • Pregnant women and/or co-parents affiliated to a social security scheme,
  • Pregnant women and/or co-parents who can read and understand French.

Non-inclusion criteria :

  • Pregnant women and/or co-parents in the second trimester of pregnancy (between 16 weeks 0 days and 28 weeks 6 days of gestation),
  • Pregnant women and/or co-parents who are legally incapacitated adults (under guardianship, conservatorship, or judicial protection),
  • Pregnant women and/or co-parents who refuse to participate in the study,
  • Pregnant women with a contraindication to breastfeeding and/or co-parents whose partner has a contraindication to breastfeeding,
  • Women and/or co-parents of a child with a medical condition or malformation affecting the child's feeding,
  • Pregnant women with a multiple pregnancy and/or co-parents being monitored for a multiple pregnancy.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Part 1 : Cross-cultural adaptation
196 mothers and 196 co-parents
Part 2 : Cultural representations during 1st trimester
155 pregnant women and 155 co-parents in the first : 310 people in all
Part 2 : Cultural representations during 3rd trimester
155 pregnant women and 155 co-parents in the third trimester of pregnancy: 310 people in all

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
French-IIFAS for mothers [Part 1]
Zeitfenster: 0 day
Psychometric properties (acceptability, floor effect, internal validity, internal consistency, construct validity) of the French version of the Iowa Infant Feeding Attitude Scale (IIFAS) among postpartum mothers in France
0 day
French-IIFAS scores for pregnant women [Part 2 1st trimester] [Part 2 3rd trimester]
Zeitfenster: 0 day
The item scores and total scores obtained by pregnant women at the first and third trimesters of pregnancy
0 day

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change of French-IIFAS from baseline at 7 days for mothers [Part 1]
Zeitfenster: 7 days
Test-retest reliability of the French version of the IIFAS questionnaire among mothers
7 days
Predictive value of French-IIFAS among mothers [Part 1]
Zeitfenster: 0 day, 8 weeks
Predictive value of the score French-IIFAS questionnaire with the infant's feeding method at 8 weeks postpartum among mothers
0 day, 8 weeks
French-IIFAS for co-parents [Part 1]
Zeitfenster: 0 day
Psychometric properties Psychometric properties (acceptability, floor effect, internal validity, internal consistency, construct validity) of the French version of the Iowa Infant Feeding Attitude Scale (IIFAS) among postpartum coparents in France
0 day
Change of French-IIFAS from baseline at 7 days for coparents [Part 1]
Zeitfenster: 0 day, 7 days
Test-retest reliability of the French version of the IIFAS questionnaire among coparents
0 day, 7 days
Predictive value of French-IIFAS among coparents [Part 1]
Zeitfenster: 0 day, 8 weeks
Predictive value of the score French-IIFAS questionnaire with the infant's feeding method at 8 weeks postpartum among coparents
0 day, 8 weeks
French-IIFAS scores for co-parents [Part 2 1st trimester] [Part 2 3rd trimester]
Zeitfenster: 0 day
The item scores and total scores obtained by co-parents at the first and third trimesters of pregnancy
0 day
Differences in French-IIFAS scores for pregnant women between the first and third trimesters of pregnancy [Part 2 1st trimester] [Part 2 3rd trimester]
Zeitfenster: 0 day
The item scores and total French-IIFAS questionnaire scores obtained by pregnant women will be compared between the first and third trimesters
0 day
Differences in French-IIFAS scores for co-parents between the first and third trimesters of pregnancy [Part 2 1st trimester] [Part 2 3rd trimester]
Zeitfenster: 0 day
The item scores and total French-IIFAS questionnaire scores obtained by the co-parents will be compared between the first and third trimesters
0 day
Background, socio-demographic and medical characteristics of pregnant women [Part 2 1st trimester] [Part 2 3rd trimester]
Zeitfenster: 0 day
Age, educational level, occupation, number of children, marital status, geographic origin, socioeconomic status, having been breastfed oneself, having personal experience with breastfeeding, having a child who has already been breastfed, optimal duration of breastfeeding, influence of the infant's feeding method on the couple's lifestyle, parent-child relationship, women's body image, plans to return to work after childbirth, intended feeding method.
0 day
Background, socio-demographic and medical characteristics of co-parents [Part 2 1st trimester] [Part 2 3rd trimester]
Zeitfenster: 0 day
Age, educational level, occupation, number of children, marital status, geographic origin, socioeconomic status, having been breastfed oneself, having personal experience with breastfeeding, having a child who has already been breastfed, optimal duration of breastfeeding, influence of the infant's feeding method on the couple's lifestyle, parent-child relationship, women's body image, plans to return to work after childbirth, intended feeding method.
0 day
Differences in scores between mothers and co-parents [Part 2 1st trimester] [Part 2 3rd trimester]
Zeitfenster: 0 day
Item scores and the total score on the IIFAS questionnaire will be compared between mothers and co-parents during the first and third trimesters of pregnancy
0 day

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Chloé BARASINSKI, University Hospital, Clermont-Ferrand

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

27. Mai 2026

Primärer Abschluss (Geschätzt)

27. Januar 2028

Studienabschluss (Geschätzt)

27. Januar 2029

Studienanmeldedaten

Zuerst eingereicht

27. Mai 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

27. Mai 2026

Zuerst gepostet (Tatsächlich)

2. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

2. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

27. Mai 2026

Zuletzt verifiziert

1. Mai 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • RNI 2025 BARASINSKI
  • ANSM (Andere Kennung: 2025-A02921-48)

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren